Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRelx Share News (REL)

Share Price Information for Relx (REL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,558.00
Bid: 3,553.00
Ask: 3,554.00
Change: -18.00 (-0.50%)
Spread: 1.00 (0.028%)
Open: 3,575.00
High: 3,580.00
Low: 3,543.00
Prev. Close: 3,576.00
REL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Tesco profit surges; Spirent Comms cuts outlook

Wed, 04th Oct 2023 07:45

(Alliance News) - Stocks in London are called lower on Wednesday, as worries about a protracted period of elevated US interest rates tank risk sentiment.

Stocks in New York and Asia suffered as bond yields hit fresh highs, after robust US jobs data added weight to the case for the Federal Reserve to keep interest rates elevated.

Figures from the US Bureau of Labor Statistics showed the number of job openings increased 690,000 to 9.61 million on the last business day of August, from 8.92 million at the end of July. The print came well above market expectations, which had been expecting the number of job openings to dip to 8.8 million at the end of August, according to FXStreet-cited consensus.

Weighing further on sentiment is the ousting of US House of Representatives speaker, Kevin McCarthy, in a brutal, historic rebellion by far-right Republicans furious at his cooperation with Democrats on the government stopgap funding deal over the weekend.

"With the House now without a majority leader, a new leader will need to be appointed, a time-consuming process if the McCarthy experience is any guide, which could complicate the prospect that we might get a new [deal to avert a government shutdown] when the current deal expires next month," CMC Markets' Michael Hewson commented.

In early company news, Tesco reported an upbeat interim update, with strong profit growth. Spirent Communications warned of weak trading since the summer, which will "very materially affect [annual] operating profit". Further afield, Novartis completed the spin-off of Sandoz, its generics and biosimilar division.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called down 27.4 points, 0.4%, at 7,442.76

----------

Hang Seng: down 1.3% at 17,100.97

Nikkei 225: closed down 2.3% at 30,526.88

S&P/ASX 200: closed down 0.8% at 6,890.20

----------

DJIA: closed down 430.97 points, 1.3%, at 33,002.38

S&P 500: closed down 1.4%, at 4,229.45

Nasdaq Composite: closed down 1.9% at 13,.59.47

----------

EUR: up at USD1.0469 (USD1.0459)

GBP: up at USD1.2078 (USD1.2065)

USD: flat at JPY149.20 (JPY149.22)

GOLD: down at USD1,821.40 per ounce (USD1,824.87)

OIL (Brent): down at USD90.64 a barrel (USD91.00)

(changes since previous London equities close)

----------

ECONOMICS

----------

Wednesday's key economic events still to come:

China - National Day Golden Week continues: financial markets closed. Hong Kong open.

Germany - ECB monetary policy conference

US Fed Michelle Bowman and FRB Kansas City President Jeffrey Schmid speak

10:00 CEST EU services PMI

11:00 CEST EU PPI

11:00 CEST EU retail trade

09:55 CEST Germany services PMI

11:00 IST Ireland unemployment

09:30 BST UK official reserves

09:30 BST UK services PMI

09:30 BST UK narrow money and reserve balances

07:00 EDT US MBA weekly mortgage applications survey

08:15 EDT US ADP national employment report

09:30 CDT US Fed Chicago President Austan Goolsbee speaks at Annual Payments Symposium

09:45 EDT US services PMI

10:00 EDT US ISM services PMI

11:00 EDT US services PMI

----------

Rishi Sunak will rail against post-Thatcher politics and attempt to portray himself as a radical reformer as he faced a backlash for abandoning the northern leg of HS2. The prime minister will use his Conservative conference speech in Manchester on Wednesday to criticise 30 years of a "broken" system incentivising "the easy decision, not the right one". With the Tories having been in charge for the majority of the last three decades, he will pitch himself as the man to "fundamentally change our country" ahead of an election expected next year.

----------

BROKER RATING CHANGES

----------

RBC raises Compass Group to 'sector perform' (underperform) - price target 1,925 (1,675) pence

----------

Goldman Sachs raises Relx to 'buy' - price target 3,405 pence

----------

UBS raises Asos to 'buy' (neutral) - price target 550 (660) pence

----------

COMPANIES - FTSE 100

----------

Tesco said revenue in the 26 weeks to August 26 climbed 5.0% to GBP34.15 billion from GBP32.52 billion a year before. The grocery chain reported strong sales across the group, with retail like-for-like sales rising 7.8%. Inflation eased over the period, Tesco said, also noting that volume and sales mix trends were ahead of expectations. Pretax profit jumped to GBP1.22 billion from GBP396 million. It left its interim dividend unchanged at 3.85p per share. It now expects to deliver between GBP2.6 billion and GBP2.7 billion retail adjusted operating profit for the financial year, and expects retail free cash flow for the year to be ahead of its medium term guidance. Bank adjusted operating profit still expected between GBP130 million and GBP160 million. Further, Tesco has so far bought back GBP503 million worth of shares from its GBP750 million share buyback programme, which runs until April.

----------

SSE updated on its interim performance for the period to September 30. The energy firm expects to report interim adjusted earnings per share of at least 30p. The guidance reflects a weaker-than-expected performance in renewables, due to adverse weather conditions. While it expects the "lower power price environment and more stable market conditions" to continue over the financial year, it still guides for annual adjusted EPS of over 150p. This is in light of its "balanced portfolio of assets across electricity networks, renewables, flexible generation and storage". However, its performance in the key winter months ahead will depend on weather conditions, plant performance and market conditions. It will update on full-year EPS guidance later in the year. "Our primary focus remains on delivery of our five-year plan out to 2027, which is the platform for up to GBP40 billion of investment in net zero over the next decade," said Finance Director Gregor Alexander.

----------

COMPANIES - FTSE 250

----------

Spirent Communications cut its annual outlook, warning of a weak near-term orderbook. "The impact of negative operating leverage will very materially affect operating profit in this financial year," the automated test and assurance solutions provider warned. The uptick in Telecommunications orders seen over the second quarter "dissipated" over the summer, and the expected rebound in September has not materialised. However, it saw strong growth in its non-telecommunications end markets. For the nine months to the end of September, it expects revenue to be around 20% behind the prior year. "We do not see the year-on-year performance improving in the remaining quarter. We continue to effectively manage gross margin, which continues to track to plan," it added.

----------

TI Fluid Systems said it will begin a share buyback programme for up to EUR40 million. It will run in a series of tranches up to a maximum consideration of EUR5 million each, with the first to start from today and end no later than March 29 next year. All shares repurchased will be cancelled.

----------

OTHER COMPANIES

----------

Novartis said it has completed its spin-off of Sandoz, its generics and biosimilars business. In July, Basel, Switzerland-based pharmaceutical firm, Novartis, announced plans for the 100% spin-off of its Sandoz business. It was then voted on by shareholders in September. This means that its generics and biosimilar business will list separately in Zurich, whilst Novartis becomes a focused medicine company. Shares of Sandoz will be listed and commence trading Wednesday under the symbol "SDZ" on the SIX Swiss Exchange. Sandoz said it is entering a "new era" as a "stand alone global and European champion in generic and biosimilar medicines". Looking ahead, Novartis reiterated its full-year guidance. It expects high-single-digit sales growth, whilst group core operating income is forecast to grow in low-double-digits to mid-teens.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
21 Oct 2021 07:28

Relx revenue, earnings growth 'above historical trends'

(Sharecast News) - Business information and analytics provider Relx reported underlying revenue growth of 6% in the first nine months of 2021 on Thursday, adding that it expected full-year underlying growth rates in revenue and adjusted operating profit, as well as constant currency growth in adjusted earnings per share, to be above historical trends.

Read more
21 Oct 2021 07:11

UK's Relx upgrades outlook above historical trends

LONDON, Oct 21 (Reuters) - European information provider Relx said it expected its full-year underlying profit, earnings and revenue growth to be above historical trends due to demand for fraud prevention and identity solutions.The British company...

Read more
14 Oct 2021 16:08

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
8 Oct 2021 09:40

LONDON BROKER RATINGS: Barclays raises Ascential; HSBC upgrades Pennon

LONDON BROKER RATINGS: Barclays raises Ascential; HSBC upgrades Pennon

Read more
7 Oct 2021 09:40

LONDON BROKER RATINGS: Morgan Stanley upgrades Centrica to Overweight

LONDON BROKER RATINGS: Morgan Stanley upgrades Centrica to Overweight

Read more
24 Sep 2021 16:08

DIRECTOR DEALINGS: Avon Protection chair and CEO buy shares

DIRECTOR DEALINGS: Avon Protection chair and CEO buy shares

Read more
13 Sep 2021 11:01

SMALL-CAP WINNERS & LOSERS: Chesnara up on Sanlam deal; Fuller's down

SMALL-CAP WINNERS & LOSERS: Chesnara up on Sanlam deal; Fuller's down

Read more
1 Sep 2021 14:37

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
17 Aug 2021 17:13

Moody's assigns Baa1 issuer rating to RELX; outlook stable

Moody's assigns Baa1 issuer rating to RELX; outlook stable

Read more
2 Aug 2021 09:37

BROKER RATINGS: Reckitt Benckiser upgraded; Smurfit Kappa and Tui cut

BROKER RATINGS: Reckitt Benckiser upgraded; Smurfit Kappa and Tui cut

Read more
30 Jul 2021 09:50

BROKER RATINGS: Credit Suisse raises Next; Barclays lifts Croda

BROKER RATINGS: Credit Suisse raises Next; Barclays lifts Croda

Read more
29 Jul 2021 16:02

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
29 Jul 2021 12:25

RELX interim profit up and tips annual growth to top historic levels

RELX interim profit up and tips annual growth to top historic levels

Read more
29 Jul 2021 09:47

UPDATE 2-FTSE 100 gains on robust earnings, bumper dividends

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Shell, Anglo American jump on strong earnings, dividends* Caterer Compass reports Q3 margins at top end of forecast* BT, Smith & Nephew top...

Read more
29 Jul 2021 08:47

UPDATE 2-Informa lifts outlook as China leads trade show recovery

* Sees 2021 revenue of around 1.8 billion stg* Shares rise 3%, among top FTSE 100 gainers* H1 profit down more than 40% (Recasts, adds CEO comments, background)By Yadarisa ShabongJuly 29 (Reuters) - Informa raised its 2021 revenue forecast on Thurs...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.